Reaktion #955931

ord-934f343f9c574c649df3333a64ecd535

Reaktionsgleichung

Br.BrCc1ccccn1
2-(bromomethyl)pyridine hydrobromide
Cc1ccc(-c2nnc(N)o2)c(C)c1
5-(2,4-dimethylphenyl)-1,3,4-oxadiazol-2-amine
O=C([O-])[O-].[K+].[K+]
K2CO3
Cc1ccc(-c2nnc(NCc3ccccn3)o2)c(C)c1
5-(2,4-Dimethylphenyl)-N-(pyridin-2-ylmethyl)-1,3,4-oxadiazol-2-amine
Ausbeute 97.0%

Lösungsmittel

Reaktionsbedingungen

Temperatur
90°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeThe solvent was removed under vacuum
  2. 2
    workup.DISSOLUTIONthe solid was dissolved in EtOAc
  3. 3
    Waschenwashed successively with aq. NaHCO3 and brine
  4. 4
    Trocknendried over MgSO4
  5. 5
    Filtrationfiltered
  6. 6
    Sonstigeevaporated
  7. 7
    SonstigeThe residue was purified on silica gel

Vorschrift

To a solution of 5-(2,4-dimethylphenyl)-1,3,4-oxadiazol-2-amine (Example 16a) (94.5 mg, 0.5 mmol) in 5 ml of dry acetonitrile was added K2CO3 (207 mg, 1.5 mmol). To the suspension was added 2-(bromomethyl)pyridine hydrobromide (127 mg, 0.5 mmol) and the mixture was stirred at 90° C. overnight. The solvent was removed under vacuum and the solid was dissolved in EtOAc, washed successively with aq. NaHCO3 and brine, dried over MgSO4 filtered and evaporated. The residue was purified on silica gel to give 5-(2,4-Dimethylphenyl)-N-(pyridin-2-ylmethyl)-1,3,4-oxadiazol-2-amine (136 mg, 97%) as a white solid. 1H NMR (300 MHz, CdCl3): δ 2.34 (s, 3H), 2.5 (s, 3H), 5.1 (s, 2H), 7.07-7.08 (m, 2H), 7.21-7.33 (m, 2H), 7.64-7.68 (m, 2H), 8.59-8.60 (d, 1H); MS (M+H, 281).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08968708B2uspto-grants-2015_03